Pfg Advisors Amgen Inc Transaction History

Pfg Advisors

$1.45 Billion
Q2 2024

A detailed history of Pfg Advisors transactions in Amgen Inc stock. As of the latest transaction made, Pfg Advisors holds 13,956 shares of AMGN stock, worth $4.46 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares

13,956

Previous 13,948 0.06%

Holding current value

$4.46 Million

Previous $3.97 Million 9.96%

% of portfolio

0.3%

Previous 0.29%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	BUY	$262.75 - $319.31 $2,102 - $2,554	8 Added 0.06%	13,956 $4.36 Million
Q1 2024 May 06, 2024	BUY	$268.87 - $324.56 $11,830 - $14,280	44 Added 0.32%	13,948 $3.97 Million
Q4 2023 Jan 19, 2024	SELL	$255.7 - $288.46 $18,154 - $20,480	-71 Reduced 0.51%	13,904 $4 Million
Q3 2023 Oct 13, 2023	BUY	$218.65 - $271.46 $58,816 - $73,022	269 Added 1.96%	13,975 $3.76 Million
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $93,207 - $110,215	435 Added 3.28%	13,706 $3.04 Million
Q1 2023 Apr 20, 2023	SELL	$225.79 - $275.2 $33,642 - $41,004	-149 Reduced 1.11%	13,271 $3.21 Million
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $11,451 - $14,550	50 Added 0.37%	13,420 $3.52 Million
Q3 2022 Oct 13, 2022	BUY	$224.46 - $253.15 $44,218 - $49,870	197 Added 1.5%	13,370 $3.01 Million
Q2 2022 Jul 13, 2022	SELL	$230.71 - $256.74 $4,614 - $5,134	-20 Reduced 0.15%	13,173 $3.21 Million
Q1 2022 Apr 19, 2022	BUY	$219.27 - $242.57 $146,472 - $162,036	668 Added 5.33%	13,193 $3.19 Million
Q4 2021 Jan 21, 2022	BUY	$198.88 - $227.6 $35,997 - $41,195	181 Added 1.47%	12,525 $2.82 Million
Q3 2021 Nov 05, 2021	SELL	$212.27 - $248.7 $102,314 - $119,873	-482 Reduced 3.76%	12,344 $2.63 Million
Q2 2021 Jul 28, 2021	BUY	$233.58 - $259.14 $278,894 - $309,413	1,194 Added 10.26%	12,826 $3.13 Million
Q1 2021 Apr 27, 2021	BUY	$221.91 - $258.6 $76,115 - $88,699	343 Added 3.04%	11,632 $2.89 Million
Q4 2020 Jan 26, 2021	BUY	$216.38 - $257.67 $80,493 - $95,853	372 Added 3.41%	11,289 $2.6 Million
Q3 2020 Oct 13, 2020	SELL	$234.65 - $260.95 $44,583 - $49,580	-190 Reduced 1.71%	10,917 $2.81 Million
Q2 2020 Jul 16, 2020	SELL	$197.81 - $242.74 $19,583 - $24,031	-99 Reduced 0.88%	11,107 $2.77 Million
Q1 2020 Apr 29, 2020	BUY	$182.24 - $241.7 $174,403 - $231,306	957 Added 9.34%	11,206 $2.65 Million
Q4 2019 Jan 14, 2020	SELL	$189.21 - $243.2 $26,678 - $34,291	-141 Reduced 1.36%	10,249 $2.44 Million
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $189,605 - $227,187	1,089 Added 11.71%	10,390 $2.04 Million
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $114,356 - $134,051	686 Added 7.96%	9,301 $1.63 Million
Q1 2019 May 08, 2019	SELL	$180.87 - $203.88 $1,446 - $1,631	-8 Reduced 0.09%	8,615 $1.55 Million
Q4 2018 Feb 19, 2019	BUY	$178.4 - $208.25 $344,490 - $402,130	1,931 Added 28.86%	8,623 $1.63 Million
Q4 2018 Jan 18, 2019	BUY	$178.4 - $208.25 $1.19 Million - $1.39 Million	6,692 New	6,692 $1.34 Million

Others Institutions Holding AMGN

# of Institutions

3,057

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.3M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfg Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Pfg Advisors with notifications on news.

Account